(19)
(11) EP 1 981 500 A1

(12)

(43) Date of publication:
22.10.2008 Bulletin 2008/43

(21) Application number: 07709303.7

(22) Date of filing: 31.01.2007
(51) International Patent Classification (IPC): 
A61K 31/4439(2006.01)
A61P 19/10(2006.01)
 A61P 19/08(2006.01)
C07D 401/04(2006.01)
(86) International application number:
PCT/SE2007/000087
(87) International publication number:
WO 2007/089192 (09.08.2007 Gazette 2007/32)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 02.02.2006 US 764551 P
28.02.2006 US 777348 P

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • BERG, Anna-Lena
    S-151 85 Södertälje (SE)
  • BHAT, Ratan
    S-151 85 Södertälje (SE)

   


(54) PHARMACEUTICAL USE OF 2-HYDROXY-3- [5-(MORPHOLIN-4-YLMETHYL) PYRIDINE-2-YL]-1H- INDOLE-5-CARBONITRILE AS A FREE BASE OR SALTS